Skip to main content

Table 2 Pulmonary function on cilostazol and placebo treatments in patients with bronchial asthma

From: Phosphodiesterase 3 inhibition and cough in elderly asthmatics

  Run-in Placebo Wash out Cilostazol
FVC as % pred. (%) 102.3 ± 5.7 104.7 ± 5.8 102.1 ± 5.1 108.4 ± 4.7
FEV1 as% pred. (%) 98.5 ± 8.2 100.4 ± 7.7 98.5 ± 6.6 106.3 ± 7.3
  1. Data are shown as mean value ± standard error of the mean.